Your browser doesn't support javascript.
loading
Microbiota: a novel regulator of pain.
Defaye, Manon; Gervason, Sandie; Altier, Christophe; Berthon, Jean-Yves; Ardid, Denis; Filaire, Edith; Carvalho, Frédéric Antonio.
  • Defaye M; Department of Physiology and Pharmacology, Inflammation Research Network, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.
  • Gervason S; GREENTECH SA, Saint-Beauzire, France.
  • Altier C; Université Clermont Auvergne, INSERM U1107, NeuroDol, CRHN Auvergne, 28 place Henri Dunant, BP 38, 63001, Clermont-Ferrand, France.
  • Berthon JY; Department of Physiology and Pharmacology, Inflammation Research Network, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.
  • Ardid D; GREENTECH SA, Saint-Beauzire, France.
  • Filaire E; Université Clermont Auvergne, INSERM U1107, NeuroDol, CRHN Auvergne, 28 place Henri Dunant, BP 38, 63001, Clermont-Ferrand, France.
  • Carvalho FA; GREENTECH SA, Saint-Beauzire, France.
J Neural Transm (Vienna) ; 127(4): 445-465, 2020 04.
Article en En | MEDLINE | ID: mdl-31552496
Among the various regulators of the nervous system, the gut microbiota has been recently described to have the potential to modulate neuronal cells activation. While bacteria-derived products can induce aversive responses and influence pain perception, recent work suggests that "abnormal" microbiota is associated with neurological diseases such as Alzheimer's, Parkinson's disease or autism spectrum disorder (ASD). Here we review how the gut microbiota modulates afferent sensory neurons function and pain, highlighting the role of the microbiota/gut/brain axis in the control of behaviors and neurological diseases. We outline the changes in gut microbiota, known as dysbiosis, and their influence on painful gastrointestinal disorders. Furthermore, both direct host/microbiota interaction that implicates activation of "pain-sensing" neurons by metabolites, or indirect communication via immune activation is discussed. Finally, treatment options targeting the gut microbiota, including pre- or probiotics, will be proposed. Further studies on microbiota/nervous system interaction should lead to the identification of novel microbial ligands and host receptor-targeted drugs, which could ultimately improve chronic pain management and well-being.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Cistitis Intersticial / Síndrome del Colon Irritable / Dolor Crónico / Dolor Visceral / Nocicepción / Disbiosis / Trastorno del Espectro Autista / Microbioma Gastrointestinal / Neuronas Aferentes Tipo de estudio: Etiology_studies Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Cistitis Intersticial / Síndrome del Colon Irritable / Dolor Crónico / Dolor Visceral / Nocicepción / Disbiosis / Trastorno del Espectro Autista / Microbioma Gastrointestinal / Neuronas Aferentes Tipo de estudio: Etiology_studies Idioma: En Año: 2020 Tipo del documento: Article